Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human monoclonal IgM antibody targeting glucose-regulated protein 78

EU orphan designation number: EU/3/13/1190   
Active ingredient: Recombinant human monoclonal IgM antibody targeting glucose-regulated protein 78
Indication: Treatment of plasma cell myeloma
Sponsor: Patrys GmbH
Friedrich-Bergius-Ring 15, D-97076 Würzburg, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/10/2013 Centralised Orphan - Designation EMA/OD/072/13 (2013)6735 of 07/10/2013